1. Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomide. Issue 12 (6th January 2009) Authors: Strangfeld, A; Hierse, F; Kekow, J; von Hinueber, U; Tony, H-P; Dockhorn, R; Listing, J; Zink, A Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 12(2009) Page Start: 1856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of the RABBIT Risk Score for serious infections. Issue 9 (5th June 2013) Authors: Zink, A; Manger, B; Kaufmann, J; Eisterhues, C; Krause, A; Listing, J; Strangfeld, A Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 9(2014) Page Start: 1673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0130 Rates and risk factors of new-onset psoriasis under different biologic agents and conventional synthetic dmard treatment. (15th June 2017) Authors: Strangfeld, A; Baganz, L; Richter, A; Manger, B; Burmester, G-R; Eisterhues, C; Wassenberg, S; Zink, A; Listing, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis. Issue 9 (13th November 2015) Authors: Richter, A; Listing, J; Schneider, M; Klopsch, T; Kapelle, A; Kaufmann, J; Zink, A; Strangfeld, A Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 9(2016) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. Issue 3 (12th July 2016) Authors: Strangfeld, A; Richter, A; Siegmund, B; Herzer, P; Rockwitz, K; Demary, W; Aringer, M; Meißner, Y; Zink, A; Listing, J Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 3(2017) Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0087 The relevance of poor prognostic factors for achieving low disease activity in patients with rheumatoid arthritis: a collaborative analysis of three german cohorts. (15th June 2017) Authors: Meissner, Y; Albrecht, K; Richter, A; Baganz, L; Huscher, D; Schneider, M; Strangfeld, A; Zink, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0674 Early treatment response to conventional dmard therapy in rheumatoid arthritis is a better predictor of low disease activity or treatment escalation at 12 and 24 months than autoantibodies or erosions. (15th June 2017) Authors: Richter, A; Strangfeld, A; Herzer, P; Kaufmann, J; Klopsch, T; Zinke, S; Listing, J; Zink, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. Issue 9 (8th May 2017) Authors: Meissner, Y; Richter, A; Manger, B; Tony, HP; Wilden, E; Listing, J; Zink, A; Strangfeld, A Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 9(2017) Page Start: 1583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0261 Pregnancy course and outcome in sle patients compared to patients with other connective tissue and inflammatory rheumatic diseases - data from a prospective cohort study. (15th June 2017) Authors: Strangfeld, A; Bungartz, C; Weiß, A; Schneider, M; Richter, J; Zink, A; Fischer-Betz, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?. Issue 11 (25th July 2011) Authors: Strangfeld, A; Eveslage, M; Schneider, M; Bergerhausen, H J; Klopsch, T; Zink, A; Listing, J Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 11(2011) Page Start: 1914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗